Rakuten Medical Announces Initiation of Global Phase 3 Trial of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for First-Line Recurrent Head and Neck Cancer ...Middle East

First patient treated in the U.S. Initial enrollment planned for the U.S., Japan, and Taiwan, with further expansion to additional countries and regions SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Rakuten Medical Announces Initiation of Global Phase 3 Trial of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for First-Line Recurrent Head and Neck Cancer )

Also on site :

• Four dead and two missing after San Antonio drenched with strongest rains in more than a decade
• Callum Turner’s Net Worth at the Time of His Engagement to Dua Lipa
• Robert De Niro, 81, Makes Rare Public Appearance With Daughter Helen, 13